These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8559384)

  • 1. Lamotrigine-induced rash in children.
    Dooley J; Camfield P; Gordon K; Camfield C; Wirrell Z; Smith E
    Neurology; 1996 Jan; 46(1):240-2. PubMed ID: 8559384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine-associated rash: risk/benefit considerations in adults and children.
    Guberman AH; Besag FM; Brodie MJ; Dooley JM; Duchowny MS; Pellock JM; Richens A; Stern RS; Trevathan E
    Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rechallenge with lamotrigine after initial rash.
    Tavernor SJ; Wong IC; Newton R; Brown SW
    Seizure; 1995 Mar; 4(1):67-71. PubMed ID: 7788112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rash in adult and pediatric patients treated with lamotrigine.
    Messenheimer JA
    Can J Neurol Sci; 1998 Nov; 25(4):S14-8. PubMed ID: 9827240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.
    Bloom R; Amber KT
    An Bras Dermatol; 2017; 92(1):139-141. PubMed ID: 28225977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic epidermal necrolysis due to lamotrigine].
    Beerhorst K; Renier WO
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1128-31. PubMed ID: 12822524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful re-introduction of lamotrigine after initial rash.
    Besag FM; Ng GY; Pool F
    Seizure; 2000 Jun; 9(4):282-6. PubMed ID: 10880290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Factors associated with serious skin reactions in children aged 12 years and under taking lamotrigine'.
    Besag F; McShane T; Neville B; Robinson R
    Dev Med Child Neurol; 1999 Jan; 41(1):68-9. PubMed ID: 10068055
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of lamotrigine and the new antiepileptic drugs: the challenge.
    Pellock JM
    J Child Neurol; 1997 Nov; 12 Suppl 1():S48-52. PubMed ID: 9429131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the incidence of lamotrigine-related skin rash.
    Wong IC; Mawer GE; Sander JW
    Ann Pharmacother; 1999 Oct; 33(10):1037-42. PubMed ID: 10534214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected lamotrigine-induced toxic epidermal necrolysis.
    Chaffin JJ; Davis SM
    Ann Pharmacother; 1997 Jun; 31(6):720-3. PubMed ID: 9184711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
    Kocak S; Girisgin SA; Gul M; Cander B; Kaya H; Kaya E
    Am J Clin Dermatol; 2007; 8(2):107-11. PubMed ID: 17428116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association between non-bullous skin reactions from lamotrigine and heterozygosity of UGT1A4 genetic variants *2(P24T) or *3(L48V) in Norwegian patients.
    Shirzadi M; Reimers A; Helde G; Sjursen W; Brodtkorb E
    Seizure; 2017 Feb; 45():169-171. PubMed ID: 28068583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine hypersensitivity in childhood epilepsy.
    Iannetti P; Raucci U; Zuccaro P; Pacifici R
    Epilepsia; 1998 May; 39(5):502-7. PubMed ID: 9596202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiepileptic treatment with lamotrigine].
    Uldall PV
    Ugeskr Laeger; 1999 Feb; 161(7):973. PubMed ID: 10051813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.